TY - JOUR
KW - Adolescent
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Analgesics, Opioid/adverse effects
KW - Child
KW - Child, Preschool
KW - Cross-Sectional Studies
KW - Female
KW - Humans
KW - Male
KW - Medicare
KW - Middle Aged
KW - Pilot Projects
KW - Practice Guidelines as Topic
KW - Process Assessment (Health Care)
KW - Respiratory Insufficiency/chemically induced/epidemiology/nursing/prevention & control
KW - Retrospective Studies
KW - Rural Health Services
KW - Safety Management
KW - United States/epidemiology
KW - Urban Health Services
KW - Young Adult
AU - C. R. Jungquist
AU - D. J. Correll
AU - L. A. Fleisher
AU - J. Gross
AU - R. Gupta
AU - C. Pasero
AU - R. Stoelting
AU - R. Polomano
A1 - 
AB - BACKGROUND: Guidelines with recommendations for monitoring type and timing of hospitalized patients for opioid-induced respiratory depression have been published, yet adverse events continue to occur. OBJECTIVE: This study reports on the monitoring practices of 8 hospitals that volunteered to pilot test a Centers for Medicare & Medicaid Services e-quality measure that was under development. Recommendations for nurse executives are provided to support patient safety. METHODS: Data on monitoring practices were collected retrospectively from the electronic medical records at 8 hospitals on all patients receiving intravenous (IV) opioids for more than 2.5 continuous hours via patient-controlled analgesia (PCA). Analysis included the percentage of patients who were monitored according to specific standards developed by a panel of technical experts with comparisons of naloxone use to monitoring practices. RESULTS: Recommended patient assessments occurred in only 8.3% of the patients. No patients who were assessed at least every 2.5 hours received naloxone. CONCLUSIONS: Care for patients receiving IV PCA is lacking in adherence to latest safety standards. Nurse executives must implement structures and processes to promote vigilance with evidence-based monitoring practices.
BT - The Journal of nursing administration
C5 - Opioids & Substance Use; Education & Workforce; HIT & Telehealth
CP - 2
CY - United States
DO - 10.1097/NNA.0000000000000301
IS - 2
JF - The Journal of nursing administration
N2 - BACKGROUND: Guidelines with recommendations for monitoring type and timing of hospitalized patients for opioid-induced respiratory depression have been published, yet adverse events continue to occur. OBJECTIVE: This study reports on the monitoring practices of 8 hospitals that volunteered to pilot test a Centers for Medicare & Medicaid Services e-quality measure that was under development. Recommendations for nurse executives are provided to support patient safety. METHODS: Data on monitoring practices were collected retrospectively from the electronic medical records at 8 hospitals on all patients receiving intravenous (IV) opioids for more than 2.5 continuous hours via patient-controlled analgesia (PCA). Analysis included the percentage of patients who were monitored according to specific standards developed by a panel of technical experts with comparisons of naloxone use to monitoring practices. RESULTS: Recommended patient assessments occurred in only 8.3% of the patients. No patients who were assessed at least every 2.5 hours received naloxone. CONCLUSIONS: Care for patients receiving IV PCA is lacking in adherence to latest safety standards. Nurse executives must implement structures and processes to promote vigilance with evidence-based monitoring practices.
PP - United States
PY - 2016
SN - 1539-0721; 0002-0443
SP - 87
EP - 94
EP - 
T1 - Avoiding Adverse Events Secondary to Opioid-Induced Respiratory Depression: Implications for Nurse Executives and Patient Safety
T2 - The Journal of nursing administration
TI - Avoiding Adverse Events Secondary to Opioid-Induced Respiratory Depression: Implications for Nurse Executives and Patient Safety
U1 - Opioids & Substance Use; Education & Workforce; HIT & Telehealth
U2 - 26796821
U3 - 10.1097/NNA.0000000000000301
VL - 46
VO - 1539-0721; 0002-0443
Y1 - 2016
ER -